Book contents
- Observation Medicine
- Observation Medicine
- Copyright page
- Contents
- Advance Praise
- About the Editors
- Contributors
- Foreword: Onward and Upward
- Preface
- Part I Administration: Key Concepts of Observation Medicine, and Developing and Maintaining an Observation Unit
- Part II Observation Medicine: Clinical Setting and Education
- Part III New Developments in Observation Medicine
- Part IV Clinical
- Subpart IVA Clinical – Cardiac
- Subpart IVB Clinical – Respiratory
- Subpart IVC Clinical – Vascular
- Subpart IVD Clinical – Neurologic
- Subpart IVE Clinical – Metabolic, Endocrine
- Chapter 39 Hyperglycemia
- Chapter 40 Hypoglycemia
- Chapter 41 Electrolyte Abnormalities
- Subpart IVF Clinical – Hematologic
- Subpart IVG Clinical – Infections
- Subpart IVH Clinical – Gastrointestinal
- Subpart IVI Clinical – Genitourinary
- Subpart IVJ Clinical – Obstetrics and Gynecology
- Subpart IVK Clinical – Pediatrics and Geriatrics
- Subpart IVL Clinical – Surgical Evaluation
- Subpart IVM Clinical – Pain Management and Musculoskeletal
- Subpart IVN Clinical – Trauma
- Subpart IVO Clinical – Toxicology
- Subpart IVP Clinical – Psychosocial
- Subpart IVQ Clinical – Disasters
- Part V Financial
- Part VI International
- Part VII Evidence Basis for Observation Medicine
- Part VIII Clinical Protocols
- Part IX Administrative Policies
- Part X Order Sets
- Prologue
- Index
- References
Chapter 40 - Hypoglycemia
from Subpart IVE - Clinical – Metabolic, Endocrine
Published online by Cambridge University Press: 31 March 2017
Edited by
Book contents
- Observation Medicine
- Observation Medicine
- Copyright page
- Contents
- Advance Praise
- About the Editors
- Contributors
- Foreword: Onward and Upward
- Preface
- Part I Administration: Key Concepts of Observation Medicine, and Developing and Maintaining an Observation Unit
- Part II Observation Medicine: Clinical Setting and Education
- Part III New Developments in Observation Medicine
- Part IV Clinical
- Subpart IVA Clinical – Cardiac
- Subpart IVB Clinical – Respiratory
- Subpart IVC Clinical – Vascular
- Subpart IVD Clinical – Neurologic
- Subpart IVE Clinical – Metabolic, Endocrine
- Chapter 39 Hyperglycemia
- Chapter 40 Hypoglycemia
- Chapter 41 Electrolyte Abnormalities
- Subpart IVF Clinical – Hematologic
- Subpart IVG Clinical – Infections
- Subpart IVH Clinical – Gastrointestinal
- Subpart IVI Clinical – Genitourinary
- Subpart IVJ Clinical – Obstetrics and Gynecology
- Subpart IVK Clinical – Pediatrics and Geriatrics
- Subpart IVL Clinical – Surgical Evaluation
- Subpart IVM Clinical – Pain Management and Musculoskeletal
- Subpart IVN Clinical – Trauma
- Subpart IVO Clinical – Toxicology
- Subpart IVP Clinical – Psychosocial
- Subpart IVQ Clinical – Disasters
- Part V Financial
- Part VI International
- Part VII Evidence Basis for Observation Medicine
- Part VIII Clinical Protocols
- Part IX Administrative Policies
- Part X Order Sets
- Prologue
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Observation MedicinePrinciples and Protocols, pp. 231 - 234Publisher: Cambridge University PressPrint publication year: 2017
References
Workgroup on Hypoglycemia, American Diabetic Association (A.D.A.), Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care, 2005. 28(5): 1245–1249.CrossRefGoogle Scholar
Lasker, RD. The diabetes control and complications trial. Implications for policy and practice. N Engl J Med, 1993. 329(14): 1035–1036.CrossRefGoogle ScholarPubMed
U.K. prospective diabetes study 16. Overview of 6 years’ therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group. Diabetes, 1995. 44(11): 1249–1258.CrossRefGoogle Scholar
Krentz, AJ, Ferner, RE, Bailey, CJ. Comparative tolerability profiles of oral antidiabetic agents. Drug Saf, 1994. 11(4): 223–241.CrossRefGoogle ScholarPubMed
Shorr, RI, Ray, WA, Daugherty, JR, et al. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med, 1997. 157(15): 1681–1686.CrossRefGoogle ScholarPubMed
Stahl, M, Berger, W. Higher incidence of severe hypoglycaemia leading to hospital admission in Type 2 diabetic patients treated with long-acting versus short-acting sulphonylureas. Diabet Med, 1999. 16(7): 586–590.CrossRefGoogle ScholarPubMed
Menzies, DJ, Dorsainvil, PA, Cunha, BA, et al. Severe and persistent hypoglycemia due to gatifloxacin interaction with oral hypoglycemic agents. Am J Med, 2002. 113(3): 232–234.CrossRefGoogle ScholarPubMed
ter Braak, EW, Appleman, AM, van de Laak, M, et al. Clinical characteristics of type 1 diabetic patients with and without severe hypoglycemia. Diabetes Care, 2000. 23(10): 1467–1471.CrossRefGoogle ScholarPubMed
Pedersen-Bjergaard, U,Reubsaet, JL, Nielsen, SL, et al. Psychoactive drugs, alcohol, and severe hypoglycemia in insulin-treated diabetes: analysis of 141 cases. Am J Med, 2005. 118(3): 307–310.CrossRefGoogle ScholarPubMed
Eliasson, L, Renstrom, E, Ammala, C, et al. PKC-dependent stimulation of exocytosis by sulfonylureas in pancreatic beta cells. Science, 1996. 271(5250): 813–815.CrossRefGoogle ScholarPubMed
Spiller, HA, Management of sulfonylurea ingestions. Pediatr Emerg Care, 1999. 15(3): 227–230.CrossRefGoogle ScholarPubMed
Dizon, AM, Kowalyk, S, Hoogwerf, BJ. Neuroglycopenic and other symptoms in patients with insulinomas. Am J Med, 1999. 106(3): 307–310.CrossRefGoogle ScholarPubMed
Hepburn, DA, Deary, IJ, Frier, BM, et al. Symptoms of acute insulin-induced hypoglycemia in humans with and without IDDM. Factor-analysis approach. Diabetes Care, 1991. 14(11): 949–957.CrossRefGoogle ScholarPubMed
Cryer, PE. Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes. Diabetologia, 2002. 45(7): 937–948.CrossRefGoogle ScholarPubMed
Cryer, PE, Davis, SN, Shamoon, H. Hypoglycemia in diabetes. Diabetes Care, 2003. 26(6): 1902–1912.CrossRefGoogle ScholarPubMed
Dagogo-Jack, SE, Craft, S, Cryer, PE. Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia. J Clin Invest, 1993. 91(3): 819–828.CrossRefGoogle Scholar
Davis, SN, Shavers, C, Davis, B, et al. Prevention of an increase in plasma cortisol during hypoglycemia preserves subsequent counterregulatory responses. J Clin Invest, 1997. 100(2): 429–438.CrossRefGoogle ScholarPubMed
Davis, SN, Shavers, C, Costa, F, et al. Role of cortisol in the pathogenesis of deficient counterregulation after antecedent hypoglycemia in normal humans. J Clin Invest, 1996. 98(3): 680–691.CrossRefGoogle ScholarPubMed
MacLeod, KM, Hepburn, DA, Frier, BM. Frequency and morbidity of severe hypoglycaemia in insulin-treated diabetic patients. Diabet Med, 1993. 10(3): 238–245.CrossRefGoogle ScholarPubMed
Abraira, C, Colwell, JA J, Nuttall, FQ, et al., Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes. Diabetes Care, 1995. 18(8): 1113–1123.CrossRefGoogle Scholar
Saudek, CD, Duckworth, WC, Giobbie-Hurder, A, et al. Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus: a randomized clinical trial. Department of Veterans Affairs Implantable Insulin Pump Study Group. JAMA, 1996. 276(16): 1322–1327.CrossRefGoogle ScholarPubMed
Schwartz, NS, Clutter, WE, Shah, SD, et al. Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. J Clin Invest, 1987. 79(3): 777–781.CrossRefGoogle Scholar
Brelje, TC, Scharp, DW, Sorenson, RL. Three-dimensional imaging of intact isolated islets of Langerhans with confocal microscopy. Diabetes, 1989. 38(6): 808–814.CrossRefGoogle ScholarPubMed
Weir, GC, Bonner-Weir, S. Islets of Langerhans: the puzzle of intraislet interactions and their relevance to diabetes. J Clin Invest, 1990. 85(4): 983–987.CrossRefGoogle ScholarPubMed
White, NH, Skor, DA, Cryer, PE, et al. Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med, 1983. 308(9): 485–491.CrossRefGoogle ScholarPubMed
Goh, HK, Chew, DE, Miranda, IG, et al. 24-Hour observational ward management of diabetic patients presenting with hypoglycaemia: a prospective observational study. Emerg Med J, 2009. 26(10): 719–723.CrossRefGoogle ScholarPubMed
- 2
- Cited by